{"id":"W2032699899","doi":"10.1158/0008-5472.sabcs-4058","title":"Combination effects of herceptin, pertuzumab and bevacizumab in a HER2-overexpressing breast cancer xenograft model.","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Bevacizumab; Breast cancer; Metastatic breast cancer; Combination therapy; Metastasis; Internal medicine; Chemotherapy; Oncology; Cancer; Pharmacology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002746968,0.0005596576,0.0004624431,0.0002355909,0.0001185969,0.0001797314,0.0003090883,0.000320443,0.001076279],"category_scores_gemma":[0.00007277136,0.0001760941,0.0003468415,0.0002156683,0.00009971937,0.000241488,0.00009224811,0.0005739863,0.0002789233],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000281471,"about_ca_system_score_gemma":0.0003069438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001905255,"about_ca_topic_score_gemma":0.002853065,"domain_scores_codex":[0.9998648,0.00003136626,0.00001262579,0.00002394476,0.00003575649,0.00003143407],"domain_scores_gemma":[0.9998919,0.00001846557,0.00002601556,0.00001159049,0.00001214392,0.00003986385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001531568,0.00126358,0.0002392973,0.0001066258,0.0000330363,0.00008647939,0.0000237576,0.0003966929,0.9925964,0.00008575536,0.0004772124,0.003159558],"study_design_scores_gemma":[0.0005518756,0.01784695,0.005173388,0.00001351861,0.00009508779,0.0004109566,0.00003479877,0.003101911,0.9685448,0.00004888906,0.004165317,0.00001247276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925939,0.002009919,0.001014814,0.0001966211,0.0001504862,0.0001206299,0.0009741861,0.0001474416,0.002792084],"genre_scores_gemma":[0.99071,0.001319834,0.002438861,0.00007237482,0.0000296129,0.0001335688,0.001254401,0.00003077388,0.00401052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001905255,"threshold_uncertainty_score":0.003788352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06386456340538994,"score_gpt":0.4504525453210939,"score_spread":0.386587981915704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}